Allelotype analysis in the evolution of chronic myelocytic leukemia

被引:46
作者
Mori, N
Morosetti, R
Lee, S
Spira, S
BenYehuda, D
Schiller, G
Landolfi, R
Mizoguchi, H
Koeffler, HP
机构
[1] UNIV CALIF LOS ANGELES, CEDARS SINAI MED CTR, SCH MED, DEPT MED, LOS ANGELES, CA 90048 USA
[2] UNIV CALIF LOS ANGELES, CEDARS SINAI MED CTR, SCH MED, DEPT CLIN PATHOL, LOS ANGELES, CA 90048 USA
[3] CATHOLIC UNIV, HEMOSTASIS RES CTR, ROME, ITALY
[4] HADASSAH MED ORG, DEPT HEMATOL, JERUSALEM, ISRAEL
[5] UNIV CALIF LOS ANGELES, SCH MED, DEPT HEMATOL ONCOL, LOS ANGELES, CA USA
[6] TOKYO WOMENS MED COLL, DEPT HEMATOL, TOKYO 162, JAPAN
关键词
D O I
10.1182/blood.V90.5.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the genetic events that may play important roles in the progression of chronic myelocytic leukemia (CML), we performed allelotype analysis in 90 patients with CML as the disease transformed to accelerated phase or blast crisis (21 myeloid and 9 lymphoid cases). DNAs were extracted from slides of bone marrow smears or from freshly isolated hone marrow mononuclear cells. The DNAs from the same individuals in both chronic phase and either blast crisis or accelerated phase were analyzed at 82 microsatellite markers, which mapped to each of the autosomal arms except, the short arms of the acrocentric chromosomes. Loss of heterozygosity (LOH) on at least one locus was observed in 21 of the 30 cases (70%) as the disease progressed, Frequent allelic loss of greater than or equal to 20% of the informative cases was observed on chromosome arms 1p (35%), 7p (21%), 19p (20%), and 20q (29%). Allelic losses were also analyzed according to phenotypes. LOH of greater than or equal to 20% was detected on 1p (29%), 18p (20%), and 20q (27%) in myeloid blast crisis, and on Ip (50%), 4p (25%), 7p (43%), 9p (29%), 18q (25%), 19p (43%), and 20q (33%) in lymphoid blast crisis. Serial cytogenetic information was available for most of our cases with LOH on these arms, and only one case had loss of both chromosomes 9 and 20. Fractional allelic loss, calculated for each sample as the total number of chromosomal arms lost/total number of arms with information, showed a median value of 0.06 and a mean of 0.098 (range 0 to 0.60), These results suggest that tumor suppressor genes especially on Ip, 7p, 19p, and 20q probably have an important role in the progression to blast crisis of CML, (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2010 / 2014
页数:5
相关论文
共 34 条
[1]   THE SPECTRUM OF MOLECULAR ALTERATIONS IN THE EVOLUTION OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ARLIN, Z ;
ADVANI, S ;
ALLEN, SL ;
GOLDMAN, J ;
SNYDER, D ;
FOTI, A ;
CLINE, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2042-2047
[2]   ALLELOTYPE STUDY OF ESOPHAGEAL-CARCINOMA [J].
AOKI, T ;
MORI, T ;
DU, XQ ;
NISIHIRA, T ;
MATSUBARA, T ;
NAKAMURA, Y .
GENES CHROMOSOMES & CANCER, 1994, 10 (03) :177-182
[3]   MOLECULAR ANALYSIS OF CHROMOSOME 20Q DELETIONS ASSOCIATED WITH MYELOPROLIFERATIVE DISORDERS AND MYELODYSPLASTIC SYNDROMES [J].
ASIMAKOPOULOS, FA ;
WHITE, NJ ;
NACHEVA, E ;
GREEN, AR .
BLOOD, 1994, 84 (09) :3086-3094
[4]  
BERNSTEIN R, 1988, SEMIN HEMATOL, V25, P20
[5]   ABNORMALITIES OF CHROMOSOME NO-17 IN MYELOPROLIFERATIVE DISORDERS [J].
BORGSTROM, GH ;
VUOPIO, P ;
DELACHAPELLE, A .
CANCER GENETICS AND CYTOGENETICS, 1982, 5 (02) :123-135
[6]   Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].
Caron, H ;
vanSluis, P ;
deKraker, J ;
Bokkerink, J ;
Egeler, M ;
Laureys, G ;
Slater, R ;
Westerveld, A ;
Voute, PA ;
Versteeg, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230
[7]  
Cave H, 1996, LEUKEMIA, V10, P1486
[8]   FREQUENT LOSS OF CHROMOSOME ARM IP DNA IN PARATHYROID ADENOMAS [J].
CRYNS, VL ;
YI, SM ;
TAHARA, H ;
GAZ, RD ;
ARNOLD, A .
GENES CHROMOSOMES & CANCER, 1995, 13 (01) :9-17
[9]   LOSS OF HETEROZYGOSITY FOR THE SHORT ARM OF CHROMOSOME-1 IN HUMAN NEUROBLASTOMAS - CORRELATION WITH N-MYC AMPLIFICATION [J].
FONG, CT ;
DRACOPOLI, NC ;
WHITE, PS ;
MERRILL, PT ;
GRIFFITH, RC ;
HOUSMAN, DE ;
BRODEUR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3753-3757
[10]  
FUJINO T, 1994, CANCER RES, V54, P4294